PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR
2026-03-31T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NAVER D2SF Makes Follow-On Investment in Nuvilab, AI Nutrition Analytics Startup
2026-03-31T    Biotechnology   Computer/Electronics   Food/Beverages   Health Care/Hospital 
Sanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence
2026-03-30T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary
2026-03-30T    Agriculture   Banking/Financial Service   Biotechnology 
Tigermed Announces 2025 Annual Results
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"
2026-03-30T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.